Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.

doi:10.3324/haematol.2011.053918

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.

Haematologica - 1 Jul 2012

Broseus Julien, Florensa Lourdes, Zipperer Esther, Schnittger Susanne, Malcovati Luca, Richebourg Steven, Lippert Eric, Cermak Jaroslav, Evans Jyoti, Mounier Morgane, Raya José Maria, Bailly François, Gattermann Norbert, Haferlach Torsten, Garand Richard, Allou Kaoutar, Besses Carlos, Germing Ulrich, Haferlach Claudia, Travaglino Erica, Luno Elisa, Pinan Maria Angeles, Arenillas Leonor, Rozman Maria, Perez Sirvent Maria Luz, Favre Bernardine, Guy Julien, Alonso Esther, Ahwij Nuhri, Jerez Andrés, Hermouet Sylvie, Maynadié Marc, Cazzola Mario, Girodon François

Abstract excerpt

BACKGROUND: Refractory anemia with ring sideroblasts associated with marked thrombocytosis was proposed as a provisional entity in the 2001 World Health Organization classification of myeloid neoplasms and also in the 2008 version, but its existence as a single entity is contested. We wish to define the clinical features of this rare myelodysplastic/myeloproliferative neoplasm and to compare its clinical outcome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sideroblastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Platelets

Share to Europe

Share to Janus Kinase 2

Share to Platelet Count

Share to Survival Analysis

Share to Thrombocythemia, Essential

Share to Thrombocytosis

Source

Open in PubMed Open full text

Identifiers

PMID: 22532522
DOI: 10.3324/haematol.2011.053918
PMCID: PMC3396675

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.PMID 22532522Read ↗

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic featuresSemantic proximity Read ↗

Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings.Semantic proximity Read ↗

Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?Semantic proximity Read ↗

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.Semantic proximity Read ↗

Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future.Semantic proximity Read ↗

Clinical Application for Diagnosis of Myelodysplatic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis.Semantic proximity Read ↗

Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation.Semantic proximity Read ↗

High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasmsSemantic proximity Read ↗

Refractory anemia with ring sideroblasts associated with thrombocytosis (RARS-T).Semantic proximity Read ↗

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.Semantic proximity Read ↗

Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.